BB BIOTECH BB Biotech AG closes the 2020 fiscal year with a profit
Transparency directive : regulatory news
|
DGAP-Ad-hoc: BB BIOTECH AG / Key word(s): Annual Results Media release of January 22, 2021 BB Biotech AG closes the 2020 fiscal year with a profit In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information about its results for its fiscal year 2020. Based on its preliminary unaudited consolidated figures, BB Biotech AG reports a profit of approximately CHF 691 million for the financial year 2020 (profit of CHF 677 million in the previous year). For an investment company, the results reflect the share price development of the companies held in the portfolio. The publication of all relevant portfolio data will take place on January 22, 2021 at 7:00 am and the complete annual report will be published on February 19, 2021.
Company profile
22-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | BB BIOTECH AG |
| Schwertstrasse 6 | |
| 8200 Schaffhausen | |
| Switzerland | |
| Phone: | +41 52 624 08 45 |
| E-mail: | info@bbbiotech.com |
| Internet: | www.bbbiotech.ch |
| ISIN: | CH0038389992 |
| WKN: | A0NFN3 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Mailand, SIX |
| EQS News ID: | 1162355 |
| End of Announcement | DGAP News Service |
|
|
1162355 22-Jan-2021 CET/CEST